Methotrexate Exposure and Risk of Cutaneous Malignant Melanoma: No Evidence of a Dose-response Relationship
Methotrexate treatment has been linked with an increased risk of melanoma. However, a possible dose-response relationship with respect to methotrexate exposure and melanoma has not been addressed. The aim of the present study was to investigate whether higher accumulated doses of methotrexate correl...
Main Authors: | Sam Polesie, Martin Gillstedt, John Paoli, Amra Osmancevic |
---|---|
Format: | Article |
Language: | English |
Published: |
Society for Publication of Acta Dermato-Venereologica
2018-06-01
|
Series: | Acta Dermato-Venereologica |
Subjects: | |
Online Access: |
https://www.medicaljournals.se/acta/content/html/10.2340/00015555-2987
|
Similar Items
-
Lethal Melanomas: A Population-based Registry Study in Western Sweden from 1990 to 2014
by: Magdalena Claeson, et al.
Published: (2017-08-01) -
Multiple Primary Melanomas: A Common
Occurrence in Western Sweden
by: Magdalena Claeson, et al.
Published: (2017-03-01) -
Methotrexate Use for Patients with Psoriasis and Risk of Cutaneous Squamous Cell Carcinoma: A Nested Case-control Study
by: Filippos Giannopoulos, et al.
Published: (2021-01-01) -
Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients
by: Usman Arshad, et al.
Published: (2021-06-01) -
Dysplastic vs. Common Naevus-associated vs. De novo Melanomas: An Observational Retrospective Study of 1,021 Patients
by: Alejandro Martin-Gorgojo, et al.
Published: (2018-03-01)